ID: ALA3629731

Max Phase: Preclinical

Molecular Formula: C31H45N5O4S

Molecular Weight: 583.80

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC[C@H](C)[C@H](NC(=O)[C@H]1CCCCN1C)C(=O)N(C)[C@H]1CCO[C@@H](c2nc(C(=O)NCCc3ccccc3)cs2)C1

Standard InChI:  InChI=1S/C31H45N5O4S/c1-5-21(2)27(34-29(38)25-13-9-10-17-35(25)3)31(39)36(4)23-15-18-40-26(19-23)30-33-24(20-41-30)28(37)32-16-14-22-11-7-6-8-12-22/h6-8,11-12,20-21,23,25-27H,5,9-10,13-19H2,1-4H3,(H,32,37)(H,34,38)/t21-,23-,25+,26+,27-/m0/s1

Standard InChI Key:  MXGDZNUOAXCJOV-UBPKPXMNSA-N

Associated Targets(non-human)

Tubulin 1327 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 583.80Molecular Weight (Monoisotopic): 583.3192AlogP: 3.81#Rotatable Bonds: 11
Polar Surface Area: 103.87Molecular Species: NEUTRALHBA: 7HBD: 2
#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 12.13CX Basic pKa: 7.09CX LogP: 3.27CX LogD: 3.10
Aromatic Rings: 2Heavy Atoms: 41QED Weighted: 0.42Np Likeness Score: -0.59

References

1. Park Y, Bae SY, Hah JM, Lee SK, Ryu JS..  (2015)  Synthesis of stereochemically diverse cyclic analogs of tubulysins.,  23  (21): [PMID:26474666] [10.1016/j.bmc.2015.10.003]

Source